Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 8, 2012, Pages 1693-1695

  Tregouet, D A ^a   Sabater Lleal, M ^b   Bruzelius, M ^b   Emmerich, J ^a   Amouyel, P ^c   Dartigues, J F ^a   Kieler, H ^b   Morange, P E ^a  

^a INSERM   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE OF THE LIVER; CYANOCOBALAMIN; FIBRINOGEN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; HOMOCYSTEINE; LIVER ENZYME; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; FIBRINOGEN BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HYPOTHESIS; LETTER; LUNG EMBOLISM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VENOUS THROMBOEMBOLISM;

ALKALINE PHOSPHATASE; CASE-CONTROL STUDIES; EUROPE; FEMALE; FUCOSYLTRANSFERASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84865246019     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04807.x     Document Type: Letter

References (8)

1. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E; CARDIoGRAM, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011; 477: 54-60.
2. Haglund AC, Ronquist G, Frithz G, Ek P. Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment. Thromb Res 2000; 98: 147-56.
3. Hazra A, Kraft P, Selhub J, Giovannucci EL, Thomas G, Hoover RN, Chanock SJ, Hunter DJ. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet 2008; 40: 1160-2.
4. Mason JB, Miller JW. The effects of vitamins B12, B6, and folate on blood homocysteine levels. Ann N Y Acad Sci 1992; 669: 197-203.
5. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9.
6. Tregouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-303.
7. Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi MC, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Trégouët DA, et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 2011; 6: e25581.
8. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-213.